Stock Price Prediction

ALVR stock currently trades at a market cap of $51.12M, with a year-to-date decline of 33.82%. Despite the negative performance, analysts maintain a "Buy" consensus, likely driven by optimism around the new CEO, Vikas Sinha, who brings extensive life sciences experience. However, the lack of revenue and ongoing legal challenges may limit near-term upside.

ALVR stock currently trades at a significant discount, with a year-to-date decline of 33.82% and a market cap of $51.12M. Despite a "Buy" consensus rating, bearish sentiment stems from leadership changes, no revenue generation in recent quarters, and ongoing legal challenges. The stock's weak fundamentals and lack of clear growth catalysts suggest further downside risk.